Parenteral iron dextran therapy: a review.

摘要: Iron dextran was introduced more than 30 yr ago for the parenteral treatment of iron deficiency anemia that is refractory to oral therapy. a preparation ferric hydroxide complexed with low molecular weight fraction dextran. one most common nutritional diseases and occurs worldwide secondary inadequate dietary iron, usually excessive gastrointestinal blood losses. Repletion stores often complicated by intolerance supplementation may require iron. Parenteral can be administered via intramuscular or intravenous route either directly as an additive total nutrition. Both routes administration cause various side effects test dose recommended before therapeutic assess risk anaphylaxis. Although efficacy safety have been convincingly demonstrated, contraindicated in setting infection.